diclofenac has been researched along with cholecalciferol in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Boorsma, DM; Bruynzeel, DP; Gibbs, S; Moed, H; Rustemeyer, T; Scheper, RJ; Stoof, TJ; von Blomberg, BM | 1 |
Goldenberg, G; Skupsky, H; Skupsky, J | 1 |
1 review(s) available for diclofenac and cholecalciferol
Article | Year |
---|---|
Disseminated superficial actinic porokeratosis: a treatment review.
Topics: Aminolevulinic Acid; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Cholecalciferol; Diclofenac; Fluorouracil; Humans; Imiquimod; Immunosuppressive Agents; Interferon Inducers; Laser Therapy; Photochemotherapy; Photosensitizing Agents; Porokeratosis; Retinoids; Vitamins | 2012 |
2 other study(ies) available for diclofenac and cholecalciferol
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Identification of anti-inflammatory drugs according to their capacity to suppress type-1 and type-2 T cell profiles.
Topics: Anti-Inflammatory Agents; Cells, Cultured; Cholecalciferol; Cyclosporine; Dermatitis, Allergic Contact; Diclofenac; Dimethyl Fumarate; Flow Cytometry; Fumarates; Humans; Hydrocortisone; Interleukin-12; Interleukin-4; Interleukin-7; Lactoferrin; Lymphocyte Activation; Nickel; Patch Tests; Th1 Cells; Th2 Cells | 2004 |